203 related articles for article (PubMed ID: 27063351)
1. Adoptive Transfer of Tracer-Alloreactive CD4
Miller ML; Chen J; Daniels MD; McKeague MG; Wang Y; Yin D; Vu V; Chong AS; Alegre ML
Am J Transplant; 2016 Oct; 16(10):2842-2853. PubMed ID: 27063351
[TBL] [Abstract][Full Text] [Related]
2. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
Front Immunol; 2018; 9():3039. PubMed ID: 30740108
[TBL] [Abstract][Full Text] [Related]
3. Evidence for cooperativity in the rejection of cardiac grafts mediated by CD4 TCR Tg T cells specific for a defined allopeptide.
Honjo K; Yan Xu X; Kapp JA; Bucy RP
Am J Transplant; 2004 Nov; 4(11):1762-8. PubMed ID: 15476474
[TBL] [Abstract][Full Text] [Related]
4. Indirect minor histocompatibility antigen presentation by allograft recipient cells in the draining lymph node leads to the activation and clonal expansion of CD4+ T cells that cause obliterative airways disease.
Richards DM; Dalheimer SL; Ehst BD; Vanasek TL; Jenkins MK; Hertz MI; Mueller DL
J Immunol; 2004 Mar; 172(6):3469-79. PubMed ID: 15004147
[TBL] [Abstract][Full Text] [Related]
5. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ
Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565
[TBL] [Abstract][Full Text] [Related]
6. TIM-3: a novel regulatory molecule of alloimmune activation.
Boenisch O; D'Addio F; Watanabe T; Elyaman W; Magee CN; Yeung MY; Padera RF; Rodig SJ; Murayama T; Tanaka K; Yuan X; Ueno T; Jurisch A; Mfarrej B; Akiba H; Yagita H; Najafian N
J Immunol; 2010 Nov; 185(10):5806-19. PubMed ID: 20956339
[TBL] [Abstract][Full Text] [Related]
7. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
8. Tracking of TCR-Transgenic T Cells Reveals That Multiple Mechanisms Maintain Cardiac Transplant Tolerance in Mice.
Miller ML; Daniels MD; Wang T; Wang Y; Xu J; Yin D; Chong AS; Alegre ML
Am J Transplant; 2016 Oct; 16(10):2854-2864. PubMed ID: 27091509
[TBL] [Abstract][Full Text] [Related]
9. Germinal Center Alloantibody Responses Mediate Progression of Chronic Allograft Injury.
Chhabra M; Alsughayyir J; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
Front Immunol; 2018; 9():3038. PubMed ID: 30728823
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice.
Liang H; Liao C; Qi Z; Sha C; Xie B; Chen J; Xia J; Wang Y; Yao Q; Zhao Y
Transpl Immunol; 2010 Feb; 22(3-4):128-36. PubMed ID: 19755159
[TBL] [Abstract][Full Text] [Related]
11. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ
J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935
[TBL] [Abstract][Full Text] [Related]
12. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
van der Touw W; Burrell B; Lal G; Bromberg JS
Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
[TBL] [Abstract][Full Text] [Related]
13. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection.
Kapp JA; Honjo K; Kapp LM; Xu Xy; Cozier A; Bucy RP
Int Immunol; 2006 Nov; 18(11):1549-62. PubMed ID: 16966495
[TBL] [Abstract][Full Text] [Related]
14. CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation.
Karim M; Feng G; Wood KJ; Bushell AR
Blood; 2005 Jun; 105(12):4871-7. PubMed ID: 15713793
[TBL] [Abstract][Full Text] [Related]
15. Visualization of the in vivo generation of donor antigen-specific effector CD8+ T cells during mouse cardiac allograft rejection: in vivo effector CD8+ T cell generation during allograft rejection.
Gilot BJ; Hara M; Jones ND; van Maurik A; Niimi M; Hadjianastassiou V; Morris PJ; Wood KJ
Transplantation; 2000 Feb; 69(4):639-48. PubMed ID: 10708123
[TBL] [Abstract][Full Text] [Related]
16. New TCR transgenic model for tracking allospecific CD4 T-cell activation and tolerance in vivo.
Sandner SE; Salama AD; Houser SL; Palmer E; Turka LA; Sayegh MH
Am J Transplant; 2003 Oct; 3(10):1242-50. PubMed ID: 14510697
[TBL] [Abstract][Full Text] [Related]
17. Alloreactive CD4 T cell activation in vivo: an autonomous function of the indirect pathway of alloantigen presentation.
Reed AJ; Noorchashm H; Rostami SY; Zarrabi Y; Perate AR; Jeganathan AN; Caton AJ; Naji A
J Immunol; 2003 Dec; 171(12):6502-9. PubMed ID: 14662850
[TBL] [Abstract][Full Text] [Related]
18. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients.
Ezzelarab MB; Zhang H; Guo H; Lu L; Zahorchak AF; Wiseman RW; Nalesnik MA; Bhama JK; Cooper DK; Thomson AW
Am J Transplant; 2016 Jul; 16(7):1999-2015. PubMed ID: 26700196
[TBL] [Abstract][Full Text] [Related]
20. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
